Summary
- Current Price
- As of today, TXG price is $57.99, down -0.28% on
- Current Price All-Time High
- TXG price is currently -72.25% below its historical high of $208.99 set on
- Market Cap
- TXG current market cap is $8B, up +358.58% over the past 365 days
- Revenue
- TXG current annual revenue is $642.82M, up +5.25% year-over-year
- Next Earnings
- The next earnings release for TXG is on
Profile
| Metric | Value |
|---|---|
| Full Name | 10x Genomics, Inc. |
| Ticker | NASDAQ: TXG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 10xgenomics.com |
| Employees | 1,306 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $57.99 | |
| Price, 1D Change | -0.28% | |
| $8B | ||
| - | ||
| - | ||
| 2.30 | ||
| $642.82M | ||
| Revenue, 1Y Change | +5.25% | |
| -$0.35 | ||
| EPS, 1Y Change | +76.98% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.35 | ||
| EPS Estimate | $0.03 | N/A |
| EPS Est. Change | +108.59% | N/A |
| $642.82M | ||
| Revenue Estimate | $619.43M | N/A |
| Revenue Est. Change | -3.64% | N/A |
| Current Price | $57.99 | |
| Price Target | $50.00 | - |
| Price Tgt. Change | -13.78% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.61 | -$1.52 | -147.22% | |
| -$0.03 | -$0.35 | -1,207.49% | |
| $0.03 | N/A | +108.59% | |
| $0.20 | N/A | +158.24% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $610.74M | $610.79M | +0.01% | |
| $640.23M | $642.82M | +0.41% | |
| $619.43M | N/A | -3.64% | |
| $678.76M | N/A | +5.59% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $57.99 | |
| $25.59 | ||
| $42.23 | ||
| $28.91 | ||
| $43.67 | ||
| $4.49 | ||
| 2.30 | ||
| $3.39 | ||
| 69.57 | ||
| 98.99% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $642.82M | ||
| -$0.35 | ||
| $443.88M | ||
| 69.05% | ||
| -$110.89M | ||
| -17.25% | ||
| -$43.54M | ||
| -6.77% | ||
| -$56.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.11 | ||
| 4.46 | ||
| 4.09 | ||
| - | ||
| 4 | ||
| 17.35 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 12.25 | ||
| 9.15 | ||
| -164.16 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $796.33M | ||
| $523.41M | ||
| $1.04B | ||
| $684.45M | ||
| $245.04M | ||
| $153.45M | ||
| $84.36M | ||
| $10.99M | ||
| $12.73M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $686.37M | ||
| $554.77M | ||
| $198.94M | ||
| $0.00 | ||
| $43.82M | ||
| $0.00 | ||
| $3.64M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $136.05M | ||
| -$13.44M | ||
| $6.80M | ||
| $5.94M | ||
| $130.12M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Stephens & Co. | → | |
| Piper Sandler | → | |
| Canaccord Genuity | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Leerink Partners | → | |
| Canaccord Genuity | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TXG
FAQ
- What is the ticker symbol for 10x Genomics, Inc.?
- The ticker symbol for 10x Genomics, Inc. is NASDAQ:TXG
- Does 10x Genomics, Inc. pay dividends?
- No, 10x Genomics, Inc. does not pay dividends
- What sector is 10x Genomics, Inc. in?
- 10x Genomics, Inc. is in the Healthcare sector
- What industry is 10x Genomics, Inc. in?
- 10x Genomics, Inc. is in the Health Information Services industry
- What country is 10x Genomics, Inc. based in?
- 10x Genomics, Inc. is headquartered in United States
- When did 10x Genomics, Inc. go public?
- 10x Genomics, Inc. initial public offering (IPO) was on September 12, 2019
- Is 10x Genomics, Inc. in the S&P 500?
- No, 10x Genomics, Inc. is not included in the S&P 500 index
- Is 10x Genomics, Inc. in the NASDAQ 100?
- No, 10x Genomics, Inc. is not included in the NASDAQ 100 index
- Is 10x Genomics, Inc. in the Dow Jones?
- No, 10x Genomics, Inc. is not included in the Dow Jones index
- When was 10x Genomics, Inc. last earnings report?
- 10x Genomics, Inc.'s most recent earnings report was on August 6, 2026
- When does 10x Genomics, Inc. report earnings?
- The next expected earnings date for 10x Genomics, Inc. is November 5, 2026
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000162828026007822/0001628280-26-007822-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg